International Clinical Trial: Deep learning Based on the Fusion of radiomics and pathomics for Heterogeneity Analysis and Prognosis Prediction of liver Cancer: A multicenter study

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115885) titled 'Deep learning Based on the Fusion of radiomics and pathomics for Heterogeneity Analysis and Prognosis Prediction of liver Cancer: A multicenter study' on Jan. 3.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The First Affiliated Hospital of Nanchang University

Condition: Hepatocellular carcinoma (HCC

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-04

Target Sample Size: Observation Group of Hepatocellular carcinoma:534;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=296723

Publishe...